Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pollard

Showing results (291-300 of 318) with videos related to

Pageof 32
Sort By:
Radiation Research|September 1, 1983
Comparative toxicity of 226Ra, 239Pu, 241Am, 249Cf, and 252Cf in C57BL/Do black and albino miceG N Taylor, C W Mays, R D Lloyd, et al.
Clinical and Experimental Immunology|January 9, 2023
Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adultsC Green, J McGinley, C Sande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology groupPhoenix A Ho, Julia Kuhn, Robert B Gerbing, et al.
Pediatric Blood & Cancer|February 10, 2015
Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemiaKatherine Tarlock, Bill Chang, Todd Cooper, et al.
Frontiers in Genetics|August 4, 2023
Tissue-specific DNA methylation variability and its potential clinical valueRyan H Miller, Chad A Pollard, Kristin R Brogaard, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|June 19, 2023
Neuropsychological Performance in Alzheimer's Disease versus Late-Life Depression: A Systematic Review and Meta-AnalysisBrianna D Barlet, Alexander O Hauson, Anna A Pollard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2017
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531Jatinder K Lamba, Lata Chauhan, Miyoung Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) StudyTodd M Cooper, Jeannette Cassar, Elena Eckroth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2019
Functional Properties of <i>KIT</i> Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid LeukemiaKatherine Tarlock, Todd A Alonzo, Yi-Cheng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapyLeslie Mortland, Todd A Alonzo, Roland B Walter, et al.
Pageof 32

Showing results (291-300 of 318) with videos related to

Sort By:
Pageof 32
Radiation Research|September 1, 1983
Comparative toxicity of 226Ra, 239Pu, 241Am, 249Cf, and 252Cf in C57BL/Do black and albino miceG N Taylor, C W Mays, R D Lloyd, et al.
Clinical and Experimental Immunology|January 9, 2023
Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adultsC Green, J McGinley, C Sande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology groupPhoenix A Ho, Julia Kuhn, Robert B Gerbing, et al.
Pediatric Blood & Cancer|February 10, 2015
Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemiaKatherine Tarlock, Bill Chang, Todd Cooper, et al.
Frontiers in Genetics|August 4, 2023
Tissue-specific DNA methylation variability and its potential clinical valueRyan H Miller, Chad A Pollard, Kristin R Brogaard, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|June 19, 2023
Neuropsychological Performance in Alzheimer's Disease versus Late-Life Depression: A Systematic Review and Meta-AnalysisBrianna D Barlet, Alexander O Hauson, Anna A Pollard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2017
CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531Jatinder K Lamba, Lata Chauhan, Miyoung Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) StudyTodd M Cooper, Jeannette Cassar, Elena Eckroth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2019
Functional Properties of <i>KIT</i> Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid LeukemiaKatherine Tarlock, Todd A Alonzo, Yi-Cheng Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapyLeslie Mortland, Todd A Alonzo, Roland B Walter, et al.
Pageof 32